ARID1A and hepatocellular carcinoma: Recent advancement of cancer exome sequencing has identified ARID1A as one of the most mutated genes in human HCC, with mutations of 10%–17% in liver cancers, and remarkably ARID1A expression levels negatively correlate with survival in HCC patients (18–20, 32).